Latest Thoratec Corp (THOR) Headlines
THORATEC CORPORATION SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against THORATEC CORPORATION and Its Board and a Lead Plaintiff Deadline of March 25, 2014 -- THOR
Business Wire - Tue Mar 11, 12:48PM CDT
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf of holders of Thoratec Corporation ("Thoratec" or the "Company") (NasdaqGS: THOR) securities between April 29, 2010 and November 27, 2013.
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Thoratec Corporation to Contact Brower Piven Before the March 25, 2014 Lead Plaintiff Deadline -- THOR
GlobeNewswire - Fri Mar 07, 5:53PM CST
Brower Piven, A Professional Corporation announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf of purchasers of Thoratec Corporation ("Thoratec" or the "Company") (Nasdaq:THOR) securities during the period between April 29, 2010 and November 27, 2013, inclusive (the "Class Period").
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Thoratec Corporation of Class Action Lawsuit and Upcoming Deadline -- THOR
GlobeNewswire - Fri Mar 07, 4:46PM CST
Pomerantz LLP has filed a class action lawsuit against Thoratec Corporation ("Thoratec" or the "Company") (Nasdaq:THOR) and certain of its officers. The class action, filed in United States District Court, Northern District of California, and docketed under 14-cv-00360, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired Thoratec securities between April 29, 2010 and November 27, 2013 both dates inclusive (the "Class Period"). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws pursuant to Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder.
Thoratec Warns About HeartMate Controller - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 2:00PM CST
Investors reacted negatively to the news, resulting in a 2.7% fall in THOR shares to $36.22 after the market closed yesterday
Stock Movements, Upcoming Conferences, Financial Results, and Public Offering Closings - Analyst Notes on Community Health Systems, United Therapeutics, Thoratec, AMRI, and Cytokinetics
PR Newswire - Wed Mar 05, 6:15AM CST
Editor Note: For more information about this release, please scroll to bottom.
Thoratec Corporation Issues Worldwide Urgent Medical Device Correction Letter to Update its Labeling Regarding the Use of the HeartMate II® LVAS Pocket System Controller
PR Newswire - Tue Mar 04, 3:30PM CST
On March 4, 2014, Thoratec Corporation initiated a voluntary worldwide Medical Device Correction in order to update its labeling and training materials for the HeartMate II® LVAS Pocket System Controller (the "Pocket Controller"). This safety advisory is being issued because some patients and caregivers have experienced difficulties with the process of changing from a primary system controller to their backup system controller. These difficulties have resulted in four deaths and five reports of loss of consciousness or other symptoms of hypoperfusion. Of these nine events, eight occurred in patients who were converted to the Pocket Controller after being originally trained on an older model, the EPC System Controller. Two of the deaths occurred in patients who attempted to exchange system controllers while alone and, contrary to the labeling, without contacting the hospital first. The Urgent Medical Device Correction Letter sent to hospitals on March 4, 2014 communicated the reported incident rate over the past year and a half since the introduction of the Pocket System Controller in August 2012.
Thoratec Announces Presentations At Investor Conferences For March 2014
PR Newswire - Wed Feb 26, 11:02AM CST
Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in two upcoming investor conferences.
Lifshitz & Miller Law Firm Announces Investigation of Emeritus Corporation, Nu Skin Enterprises, Inc., The Medicines Company, Thoratec Corporation and TriQuint Semiconductor, Inc.
PR Newswire - Wed Feb 26, 9:50AM CST
Emeritus Corporation
THORATEC CORPORATION SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against THORATEC CORPORATION and Its Board and a Lead Plaintiff Deadline of March 25, 2014 -- THOR
GlobeNewswire - Tue Feb 25, 12:05PM CST
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf of holders of Thoratec Corporation ("Thoratec" or the "Company") (Nasdaq:THOR) securities between April 29, 2010 and November 27, 2013.
Lawsuit on Behalf of Investors in Thoratec Corporation (THOR) Announced by Shareholders Foundation
GlobeNewswire - Mon Feb 24, 8:40AM CST
The Shareholders Foundation, Inc. announces that a lawsuit was filed on behalf of certain purchasers of Thoratec Corporation (THOR) common stock over alleged violations of Federal Securities Laws by Thoratec Corporation in connection with certain allegedly false and misleading statements made between April 29, 2010 and November 27, 2013.
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Thoratec Corporation and Certain Officers - THOR
PR Newswire - Fri Feb 21, 2:28PM CST
Pomerantz LLP has filed a class action lawsuit against Thoratec Corporation ("Thoratec" or the "Company")(NASDAQ: THOR) and certain of its officers. The class action, filed in United States District Court, Northern District of California, and docketed under 14-cv-00360, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired Thoratec securities between April 29, 2010 and November 27, 2013 both dates inclusive (the "Class Period"). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws pursuant to Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder.
Downtrend Call Working As Thoratec Stock Falls 11.4% (THOR)
Comtex SmarTrend(R) - Tue Feb 11, 9:48AM CST
SmarTrend identified a Downtrend for Thoratec (NASDAQ:THOR) on December 2nd, 2013 at $38.94. In approximately 2 months, Thoratec has returned 11.43% as of today's recent price of $34.49.
NTP Software Extends Relationship with Hitachi Data Systems to Enhance Family of Integrated Intelligent Storage Solutions
PR Newswire - Tue Feb 11, 7:30AM CST
NTP Software®, the worldwide leader in File Data Management, today announced that it has extended its relationship with technology partner Hitachi Data Systems to enhance its Hitachi Unified Storage and Hitachi NAS Platform line of products.
Thoratec Earnings Meet Ests but Fall Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 10, 12:25PM CST
THOR's revenues in the quarter declined marginally by 0.2% to $128.2 million
Barbarian At The Gate: Thoratec Corporation (THOR)
at The Street - Wed Feb 05, 9:05AM CST
Trade-Ideas LLC identified Thoratec Corporation (THOR) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
Thoratec® Reports Fourth Quarter 2013 Results
PR Newswire - Tue Feb 04, 3:02PM CST
Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support (MCS) therapies to save, support and restore failing hearts, today reported its financial results for the fourth quarter of 2013.
Thoratec Has Returned 12.5% Since SmarTrend Recommendation (THOR)
Comtex SmarTrend(R) - Tue Feb 04, 9:24AM CST
SmarTrend identified a Downtrend for Thoratec (NASDAQ:THOR) on December 2nd, 2013 at $38.94. In approximately 2 months, Thoratec has returned 12.51% as of today's recent price of $34.07.
Glancy Binkow & Goldberg LLP Files Class Action Lawsuit Against Thoratec Corporation
Business Wire - Tue Feb 04, 7:04AM CST
Glancy Binkow & Goldberg LLP, representing investors of Thoratec Corporation ("Thoratec" or the "Company") (NASDAQ:THOR), has filed a class action lawsuit in the United States District Court for the Northern District of California on behalf of a class (the "Class") comprising all purchasers of Thoratec securities between April 29, 2010 and November 27, 2013, inclusive (the "Class Period").
THORATEC CORPORATION SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against THORATEC CORPORATION and Its Board and a Lead Plaintiff Deadline of March 25, 2014 -- THOR
Business Wire - Tue Mar 11, 12:48PM CDT
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf of holders of Thoratec Corporation ("Thoratec" or the "Company") (NasdaqGS: THOR) securities between April 29, 2010 and November 27, 2013.
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Thoratec Corporation to Contact Brower Piven Before the March 25, 2014 Lead Plaintiff Deadline -- THOR
GlobeNewswire - Fri Mar 07, 5:53PM CST
Brower Piven, A Professional Corporation announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf of purchasers of Thoratec Corporation ("Thoratec" or the "Company") (Nasdaq:THOR) securities during the period between April 29, 2010 and November 27, 2013, inclusive (the "Class Period").
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Thoratec Corporation of Class Action Lawsuit and Upcoming Deadline -- THOR
GlobeNewswire - Fri Mar 07, 4:46PM CST
Pomerantz LLP has filed a class action lawsuit against Thoratec Corporation ("Thoratec" or the "Company") (Nasdaq:THOR) and certain of its officers. The class action, filed in United States District Court, Northern District of California, and docketed under 14-cv-00360, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired Thoratec securities between April 29, 2010 and November 27, 2013 both dates inclusive (the "Class Period"). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws pursuant to Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder.
Thoratec Warns About HeartMate Controller - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 2:00PM CST
Investors reacted negatively to the news, resulting in a 2.7% fall in THOR shares to $36.22 after the market closed yesterday
Stock Movements, Upcoming Conferences, Financial Results, and Public Offering Closings - Analyst Notes on Community Health Systems, United Therapeutics, Thoratec, AMRI, and Cytokinetics
PR Newswire - Wed Mar 05, 6:15AM CST
Editor Note: For more information about this release, please scroll to bottom.
Thoratec Corporation Issues Worldwide Urgent Medical Device Correction Letter to Update its Labeling Regarding the Use of the HeartMate II® LVAS Pocket System Controller
PR Newswire - Tue Mar 04, 3:30PM CST
On March 4, 2014, Thoratec Corporation initiated a voluntary worldwide Medical Device Correction in order to update its labeling and training materials for the HeartMate II® LVAS Pocket System Controller (the "Pocket Controller"). This safety advisory is being issued because some patients and caregivers have experienced difficulties with the process of changing from a primary system controller to their backup system controller. These difficulties have resulted in four deaths and five reports of loss of consciousness or other symptoms of hypoperfusion. Of these nine events, eight occurred in patients who were converted to the Pocket Controller after being originally trained on an older model, the EPC System Controller. Two of the deaths occurred in patients who attempted to exchange system controllers while alone and, contrary to the labeling, without contacting the hospital first. The Urgent Medical Device Correction Letter sent to hospitals on March 4, 2014 communicated the reported incident rate over the past year and a half since the introduction of the Pocket System Controller in August 2012.
Thoratec Announces Presentations At Investor Conferences For March 2014
PR Newswire - Wed Feb 26, 11:02AM CST
Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in two upcoming investor conferences.
Lifshitz & Miller Law Firm Announces Investigation of Emeritus Corporation, Nu Skin Enterprises, Inc., The Medicines Company, Thoratec Corporation and TriQuint Semiconductor, Inc.
PR Newswire - Wed Feb 26, 9:50AM CST
Emeritus Corporation
THORATEC CORPORATION SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against THORATEC CORPORATION and Its Board and a Lead Plaintiff Deadline of March 25, 2014 -- THOR
GlobeNewswire - Tue Feb 25, 12:05PM CST
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf of holders of Thoratec Corporation ("Thoratec" or the "Company") (Nasdaq:THOR) securities between April 29, 2010 and November 27, 2013.
Lawsuit on Behalf of Investors in Thoratec Corporation (THOR) Announced by Shareholders Foundation
GlobeNewswire - Mon Feb 24, 8:40AM CST
The Shareholders Foundation, Inc. announces that a lawsuit was filed on behalf of certain purchasers of Thoratec Corporation (THOR) common stock over alleged violations of Federal Securities Laws by Thoratec Corporation in connection with certain allegedly false and misleading statements made between April 29, 2010 and November 27, 2013.
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Thoratec Corporation and Certain Officers - THOR
PR Newswire - Fri Feb 21, 2:28PM CST
Pomerantz LLP has filed a class action lawsuit against Thoratec Corporation ("Thoratec" or the "Company")(NASDAQ: THOR) and certain of its officers. The class action, filed in United States District Court, Northern District of California, and docketed under 14-cv-00360, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired Thoratec securities between April 29, 2010 and November 27, 2013 both dates inclusive (the "Class Period"). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws pursuant to Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder.
Downtrend Call Working As Thoratec Stock Falls 11.4% (THOR)
Comtex SmarTrend(R) - Tue Feb 11, 9:48AM CST
SmarTrend identified a Downtrend for Thoratec (NASDAQ:THOR) on December 2nd, 2013 at $38.94. In approximately 2 months, Thoratec has returned 11.43% as of today's recent price of $34.49.
NTP Software Extends Relationship with Hitachi Data Systems to Enhance Family of Integrated Intelligent Storage Solutions
PR Newswire - Tue Feb 11, 7:30AM CST
NTP Software®, the worldwide leader in File Data Management, today announced that it has extended its relationship with technology partner Hitachi Data Systems to enhance its Hitachi Unified Storage and Hitachi NAS Platform line of products.
Thoratec Earnings Meet Ests but Fall Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 10, 12:25PM CST
THOR's revenues in the quarter declined marginally by 0.2% to $128.2 million
Barbarian At The Gate: Thoratec Corporation (THOR)
at The Street - Wed Feb 05, 9:05AM CST
Trade-Ideas LLC identified Thoratec Corporation (THOR) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
Thoratec® Reports Fourth Quarter 2013 Results
PR Newswire - Tue Feb 04, 3:02PM CST
Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support (MCS) therapies to save, support and restore failing hearts, today reported its financial results for the fourth quarter of 2013.
Thoratec Has Returned 12.5% Since SmarTrend Recommendation (THOR)
Comtex SmarTrend(R) - Tue Feb 04, 9:24AM CST
SmarTrend identified a Downtrend for Thoratec (NASDAQ:THOR) on December 2nd, 2013 at $38.94. In approximately 2 months, Thoratec has returned 12.51% as of today's recent price of $34.07.
Glancy Binkow & Goldberg LLP Files Class Action Lawsuit Against Thoratec Corporation
Business Wire - Tue Feb 04, 7:04AM CST
Glancy Binkow & Goldberg LLP, representing investors of Thoratec Corporation ("Thoratec" or the "Company") (NASDAQ:THOR), has filed a class action lawsuit in the United States District Court for the Northern District of California on behalf of a class (the "Class") comprising all purchasers of Thoratec securities between April 29, 2010 and November 27, 2013, inclusive (the "Class Period").
